[Pharmacological treatment of osteitis deformans (Paget's bone disease)].
Brixen
Kim T
KT
Odense Universitetshospital, Endokrinologisk Afdeling M, og Arhus Universitetshospital, Arhus Sygehus, Medicinsk-endokrinologisk Afdeling C. kim.brixen@ouh.fyns-amt.dk
Abrahamsen
Bo
B
Kassem
Moustapha S
MS
Mosekilde
Leif
L
D019386:Alendronate / Q000008:administration & dosage; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage; D000963:Antimetabolites / Q000008:administration & dosage; D002116:Calcitonin / Q000008:administration & dosage; D004002:Clodronic Acid / Q000008:administration & dosage; D004164:Diphosphonates / Q000008:administration & dosage; D012968:Etidronic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D010001:Osteitis Deformans / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D000077268:Pamidronate; D011877:Radionuclide Imaging; D000068296:Risedronic Acid
D018712:Analgesics, Non-Narcotic; D000963:Antimetabolites; D004164:Diphosphonates; D004002:Clodronic Acid; D002116:Calcitonin; D000068296:Risedronic Acid; D012968:Etidronic Acid; D000077268:Pamidronate; D019386:Alendronate